Sumitomo Mitsui Trust Holdings Inc. Raises Stock Holdings in Neurocrine Biosciences, Inc. (NASDAQ:NBIX)

Sumitomo Mitsui Trust Holdings Inc. increased its position in Neurocrine Biosciences, Inc. (NASDAQ:NBIX – Free Report) by 5.3% during the 4th quarter, Holdings Channel.com reports. The firm owned 243,935 shares of the company’s stock after purchasing an additional 12,382 shares during the period. Sumitomo Mitsui Trust Holdings Inc.’s holdings in Neurocrine Biosciences were worth $32,141,000 […]

Related Keywords

Metis ,Sakha Yakutiya ,Russia ,United States ,Eiry Roberts ,Darin Lippoldt ,Neurocrine Biosciences ,Barclays ,Sumitomo Mitsui Trust Holdings Inc ,Neurocrine Biosciences Inc ,First Republic Investment Management Inc ,Securities Exchange Commission ,Red Spruce Capital ,Sunbelt Securities Inc ,Metis Global Partners ,Holdings Channel ,Cantor Fitzgerald ,Jpmorgan Chase Co ,Nasdaq ,Sumitomo Mitsui Trust Holdings ,Free Report ,Mitsui Trust Holdings ,Financial Advisors ,Spruce Capital ,Global Partners ,First Republic Investment Management ,Republic Investment Management ,Get Free Report ,Exchange Commission ,Visit Holdingschannel ,Neurocrine Biosciences Daily ,Nasdaq Nbix ,Nbix ,Medical ,64125c10 ,Sec Filings ,13f ,Hedge Fund Holdings ,Institutional Investor Holdings ,